The ATVC Team specializes in commercializing regenerative medicine (RM) and advanced therapy products. Learn more about the unique expertise of each member of our interdisciplinary team by clicking on their names.
Michael Heke Ph.D
Chief Scientific Officer
& Managing Director
Chairman, CEO, Co-Founder &
Frank Razavi MEng MBA
Co-Managing Member & Quality
Michael Crowley, J.D. is serial technology and financial industry entrepreneur who is also both a university collaborator with RIT’s College of Engineering Technology and a Research Professor of Innovation & Entrepreneurship; Professor Crowley is also the Co-Founder & Executive Director of the AT Venture Center and the Founder of the US-China Center for Advanced Technology Venture Creation, LLC
Erin believes that all startup businesses would gain tremendous benefit and cost savings by implementing a flexible and effective quality management system (QMS) from the very start of their business, because their QMS would ultimately support their overall business growth.
Dr. Michael Heke has more than 20 years experience in stem cell research. He is currently a Senior Research Scientist in the Department of Biology specializing in the study of stem cells.
As the AT Venture Center’s Director of Commercialization & Licensing, Frank oversees the center’s commercialization related transactions and intellectual property (IP) licensing solutions provided to technology firms and advanced technology institutions (universities, research centers, government labs, etc.) housed in Western New York and throughout the US.
Director of Laboratory Operations Processing
Xianling (Ben) Wang Ph.D
Eileen Crowley Ph.D
Director of Nanotechnologies
Tom Conley is a lab technician with broad experience in biomedical research. As senior technician for Dr. Omar Aljitawi at the University of Rochester he helped develop the Matrix into the remarkable product it is today.
Eileen D. Crowley is a writer, scriptwriter, media producer & editor, and communications campaign consultant. Since 1975, she has provided her skills in public relations, employee relations, and media production to corporations and non-profit organizations. She has been honored to serve as a consultant to ATVC, Sanatela, and Regenerelle since the companies’ earliest days.
As the AT Venture Center’s Director of Nanotechnologies, Xianliang (Ben) Wang oversees the center’s technology for evaluation, verification and Technology-Driven Market Intelligence (TDMI) and Technology Scouting (TS). Ben also conducts comprehensive review regarding technology readiness levels (TRL) and provides project management. Ben also performs technology analysis and due diligence according to market information and end-user requirements and provides the roadmap for the Center’s related transactions.
Ph.D Weimin Liu Valenti
Biomedical Engineering Communications Intern
A third year biomedical engineering student at RIT has become a part of the ATVC team in the last year to work on the translation between visual media and technical knowlegde. His background in lab studies and biology has allowed for a fluid transition into creating content for our company in a variety of capacities.
Weimin has had a variety of positions that has given her a unique composition of technical and leadership capabilities. As a scientific advisor Weimin is utilizing her specialization to suggest research directives to take.
More than 500 licensing deals successfully completed
With experience of raising more than $2.2 Billion
20+ Advanced Technology companies launched and commercialized
Advised numerous Fortune 500 companies and hundreds of technology and manufacturing companies